An Op-Ed appeared in today’s New York Times criticizing the United States Food and Drug Administration’s conflation of counterfeit drugs with legitimate medications imported by Americans seeking lower prices for their own use.
Follow
Free to Share
Comments on:
- An error has occurred, which probably means the feed is down. Try again later.
Civil Society Documents
- An error has occurred, which probably means the feed is down. Try again later.
Comments on:
- An error has occurred, which probably means the feed is down. Try again later.
industry | infojustice
- Aspen Doesn’t Want You to Own Your Own Casebooks
- Still Profitable After All These Years
- Recording Industry Reports Growth from User-Generated Content and New Projects in Emerging Economies
- EC Trade Negotiators and Industry Discuss How to ‘Re-Educate’ Public About Intellectual Property Rights (talk about employment)
- Witnesses at U.S. Trade Hearing Offer Opinions (and Warnings) on Intellectual Property in Upcoming Negotiations with the EU